Correlation Between Cullinan Oncology and Olema Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Olema Pharmaceuticals, you can compare the effects of market volatilities on Cullinan Oncology and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Olema Pharmaceuticals.
Diversification Opportunities for Cullinan Oncology and Olema Pharmaceuticals
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Cullinan and Olema is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Olema Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Olema Pharmaceuticals
Given the investment horizon of 90 days Cullinan Oncology is expected to generate 3.24 times less return on investment than Olema Pharmaceuticals. But when comparing it to its historical volatility, Cullinan Oncology LLC is 1.28 times less risky than Olema Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Olema Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 525.00 in Olema Pharmaceuticals on January 15, 2025 and sell it today you would lose (119.00) from holding Olema Pharmaceuticals or give up 22.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Olema Pharmaceuticals
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Olema Pharmaceuticals |
Cullinan Oncology and Olema Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Olema Pharmaceuticals
The main advantage of trading using opposite Cullinan Oncology and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |